Celia Lin
CIK 1859386 · View on SEC EDGAR ↗
First SEC filing: May 13, 2021 · Latest: May 13, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 21, 2023 | VERA | S 10b5-1 | 1,490 | $16.65 | $24,808 | 11,010 Direct | -11.92% | Disposed | 89.6% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 15, 2023 | VERA | Stock Option (right to buy) | Class A Common Stock (100,000) | $7.87 | Feb. 14, 2033 | 100,000 | Acquired |
| Feb. 16, 2022 | VERA | Stock Option (right to buy) | Class A Common Stock (52,412) | $20.94 | Feb. 15, 2032 | 52,412 | Acquired |
| May 13, 2021 | VERA | Stock Option (right to buy) | Class A Common Stock (16,916) | $11.00 | May 12, 2031 | 16,916 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 13, 2021 | VERA | Stock Options (right to buy)→ Class A Common Stock (230,821) | 230,821 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
VERA
M.D.(6)Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $457,763 | — | — | $559,910 | — | — | $3,000 | $1,020,673 |
| 2022 | $440,487 | — | $232,500 | $733,123 | $176,840 | — | — | $1,582,950 |
| 2021 | $361,205 | $150,000 | — | $797,776 | $134,616 | — | — | $1,443,597 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.